KYKadir Yaray

Kadir Yaray

*This is an algorithmically generated author record based on publicly available information.

Kadir Yaray has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Ionising Radiation Suppresses rAPC-Induced NLRP3 Expression and Associated Signaling in Rat Brain: Evidence for a Radiation-Sensitive Molecular Phenotype

    by Hilal Akalın, İzEm Olcay Şahin, Dicle Aslan, Nuriye Gökçe, Kadir Yaray

    Purpose: Recombinant activated protein C (rAPC) is widely regarded as an anti-inflammatory and cytoprotective agent; however, its molecular effects in the irradiated central nervous system remain poorly characterized. This study aims to characterize the gene expression profile triggered by rAPC in the rat brain and to evaluate how ionizing radiation alters these molecular (apoptotic and neuroinflammatory) responses.Material and Methods: Male Wistar Albino rats were randomly assigned to four experimental groups: untreated control, total body irradiation (9 Gy, TBI), rAPC (0.4 mg/kg, intravenous) alone, and TBI followed by rAPC. Brain tissue was collected for gene expression analysis of apoptosis, neuroinflammation, and oxidative stress-related markers.Results: Five genes showed significant omnibus effects. BAX expression (ε² = 0.62) was significantly reduced by both irradiation and rAPC alone; the combination group showed higher BAX than the irradiation-only group, suggesting partial restoration by rAPC. BCL-2 was reduced by irradiation and p53 was reduced by rAPC alone (η² = 0.38). Strikingly, rAPC alone selectively upregulated NLRP3 inflammasome expression (p = 0.023) with a consistent directional increase in TNF-α, a pro-inflammatory activation signature absent in irradiated groups. No significant changes were observed in oxidative stress markers, COX-2, FGFR, or CASP3. Conclusion: These findings reveal a radiation-sensitive molecular phenotype for rAPC in rat brain tissue. rAPC alone upregulates Nlrp3 expression and associated signaling while simultaneously reducing P53 and Bax expression, defining a multifaceted molecular profile that is substantially modified in the irradiated context.

  • The evaluation of the protective effect of selenium-L-methionine on testicular tissue damage induced by radiation

    by Kudret Ensarioğlu Baktır, Oguz Galip Yıldız, Numan Baydilli, Eda Koseoglu, Kadir Yaray, Merve Civan, Arzu Hanım Yay

    Radiation induces pronounced and widespread histopathological damage in the testes, which exhibit a high degree of radiosensitivity; consequently, the utilization of effective radioprotective agents has become increasingly crucial for mitigating radiation-associated toxic outcomes, particularly infertility. The present investigation aimed to comprehensively evaluate the capacity of selenium-L-methionine to mitigate radiation-induced histopathological and molecular alterations within testicular tissue, thereby assessing its potential as a radioprotective agent. Rats were randomized into four groups: Group 1 (control), Group 2 (rad group), which received a single 10 Gy irradiation on day 2; Group 3 (sel group), which received intraperitoneal selenium-L-methionine (4 mg/kg) for six consecutive days; and Group 4 (rad+sel group), which received the same selenium-L-methionine regimen followed by 10 Gy irradiation 30 minutes after the second day's administration. On the seventh day, all animals were euthanized, and testicular tissue and blood samples were collected for biochemical and histopathological analyses. In the testicular tissues of the radiation-exposed groups, deformed and abnormal seminiferous tubule structures, a reduction in germ cell numbers, and sloughing of tubular epithelial cells were observed. Seminiferous tubule diameters, Johnsen's testicular biopsy scores, epididymal sperm motility, and the expression levels of Connexin 43, HSP70, PCNA, StAR, CAT, and SOD were decreased in the irradiated group, whereas TGFB1, IL-6, and MMP9 levels were increased. Selenium-L-methionine treatment largely reversed these radiation-induced changes. The addition of selenium-L-methionine to radiotherapy yielded promising radioprotective outcomes, and this therapeutic effect positions selenium-L-methionine as a potential novel radioprotective agent. Furthermore, the immunohistochemical markers used in the study-including MMP9, Connexin 43, HSP70, PCNA, and StAR served as sensitive indicators for detecting radiation-induced damage in testicular tissue. Nevertheless, larger-scale and long-term studies are required to validate these findings and to further substantiate the potential use of selenium-L-methionine as a radioprotective agent in clinical practice.